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Abstract: Substituted semicarbazones/thiosemicarbazones and their copper complexes have been 
prepared and several single crystal structures examined. The copper complexes of these 
semicarbazone/thiosemicarbazones were prepared and several crystal structures examined. The single 
crystal X-ray structure of the pyridyl-substituted semicarbazone showed two types of copper 
complexes, a monomer and a dimer. We also found that the p-nitrophenyl semicarbazone formed a 
conventional „magic lantern‟ acetate-bridged dimer. Electron Paramagnetic Resonance (EPR) of 
several of the copper complexes were consistent with the results of single crystal X-ray 
crystallography. The EPR spectra of the p-nitrophenyl semicarbazone copper complex in 
dimethylsulfoxide (DMSO) showed the presence of two species, confirming the structural 
information. Since thiosemicarbazones and semicarbazones have been reported to exhibit anticancer 
activity, we examined the anticancer activity of several of the derivatives reported in the present study 
and interestingly only the thiosemicarbazone showed activity while the semicarbazones were not 
active indicating that introduction of sulphur atom alters the biological profile of these 
thiosemicarbazones.  
_______________________________________________________________________________   
This paper is dedicated in memory of Prof. Graeme Hanson, a friend, scholar and mentor for his 
dedicated and tireless contribution to science. 
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Introduction:  
Thiosemicarbazones and semicarbazones are important classes of compounds that coordinate with 
many metal ions because of the presence of several donor atoms such as nitrogen, oxygen and sulphur 
in their structural core. The preparation and characterization of diversely substituted 
thiosemicarbazones/semicarbazones have been explored as early as the 1950s[1] and coordination of 
these compounds with metal ions were extensively studied in the 1960s[2] Although these early 
discoveries were milestones in the development of thiosemicarbazone/semicarbazone compounds, the 
lack of structural evidence, for example X-ray single crystal structure, may raise doubts about the 
architecture of some of the metal complexes.  Lobana et.al [3] have compiled a detailed review on the 
bonding and structural characteristics of thiosemicarbazones in particular, and reported the 
development of newer strategies for preparing newer derivatives. In the recent years attention has 
focussed on the biological applications of these compounds. In this regard, it has been found that 
some thiosemicarbazones have potent anticancer activity [4-14] The use of iron chelators containing 
thiosemicarbazones has also been extensively studied [15-26]
 
as has the anticancer activity of novel 
thiosemicarbazones generated through the combination of retro fragments. Some thiosemicarbazones 
have been found to have antibacterial and antifungal activity [27-29] and the pharmacological profile 
of thiosemicarbazones attached to a heterocyclic core has been reported by Singhal et al [30]  The 
biological profile exhibited by these thiosemicarbazone and semicarbazone derivatives has led to 
work in which these compounds have been complexed with positron emitting isotopes (e.g. 
64
Cu, 
68
Ga) for use as imaging agents. The radio-metal complexes (most notably 
64
Cu) of these ligands have 
been investigated for their applications as molecular imaging agents. [31-37] Pascu et al [38-40]
 
have 
synthesized a series of 
68
Ga
  
complexes of bis-thiosemicarbazones to evaluate their imaging potential. 
Interestingly, they report that the reaction of GaCl3 with these ligands results in the formation of a 
square based pyramidal mono-chloride metal complex, prompting us to propose the potential of 
exchanging this chloride with other ligands, particularly other halogens. This paper describes the 
copper complexes of semicarbazones which are relevant to PET ( Positron emission tomography) 
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imaging however the corresponding iron or manganese complexes can be utilized as contrast agents 
for magnetic resonance imaging. We were specifically interested in the recent application of 
coordination complexes of Group 13 metal ions with fluoride. McBride et al and others [41-48] have 
reported the formation of inorganic aluminium complexes with the radioisotope 
18
F which show 
excellent stability, and have highlighted that these provide simple moieties which can be incorporated 
into a wide range of biomolecules with potential as positron emitting tomography (PET) imaging 
agents. We prepared new semicarbazones and thiosemicarbazones and their copper complexes, 
studied their structural characteristics and evaluated their biological profiles.  
Experimental: All chemicals were obtained from Sigma Aldrich and were used without further 
purification. NMR spectra (Nuclear Magnetic Resonance) were recorded in d6-DMSO) (deuterated 
DMSO) and the chemical shifts are reported relative to DMSO at 2.54 ppm. The NMR data were 
acquired on a Bruker 700 MHz NMR spectrometer equipped with a cryoprobe. The proton spectra 
where acquired with a sweep width of 18 ppm cantered at 7 ppm. The carbon spectra were acquired 
with a sweep width of 220 ppm centered at 110 ppm. The COSY (Correlation Spectroscopy) 
experiments were acquired with a sweep width of 18 ppm using a 90° pulse of 9 µs with 256 
increments respectively. The 
13
C HSQC spectra (Heteronuclear Single Quantum Correlation) were 
acquired with sweep widths of 18 and 160 ppm for proton and carbon respectively and the carbon 
centered at 80 ppm. Additionally HMBC (Heteronuclear Multiple Bond Correlation) spectral data 
were also acquired to establish the structures of the compounds (
13
C sweep width of 220 ppm). The 
raw data were usually multiplied by an exponential or shifted sine squared function before performing 
the Fourier transform. DOSY spectra (Diffusion-ordered spectroscopy ) were done using standard 
parameters. UV/Visible spectra (Ultraviolet/Visible) were obtained using a Thermoscientific 
Nanodrop model 2000C Spectrophotometer using methanol or DMSO as solvent. The IR (Infrared) 
spectra were acquired using a Nicolet Diamond model 5700 Fourier Transform Infrared spectrometer. 
The samples were used as powders and introduced in the spectrometer. For other samples, chloroform 
was used as a solvent and was allowed to evaporate before obtaining IR spectra.  
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Molecular Modeling: Monte Carlo Conformational (MCMM) searching was performed using 
Macromodel v10.0 (Schrodinger, New York) for syn and anti-isomers. Torsional sampling (MCMM) 
performed with 1000 steps per rotatable bond. Each step was minimised with the OPLS-2005 ( 
polarizable and non polarizable) force field using the TNCG (Truncated Newton Conjugate Gradient) 
method with maximum iterations of 50,000 and energy convergence threshold of 0.02. All other 
parameters were left as the default values. The lowest energy conformations (< 3 kcal/mol from 
global minimum, were further optimised using DFT (Density Functional Theory) calculations in 
Gaussian (B3LYP/6311+G (d,p), with DMSO solvent).  
Synthesis of semicarbazones and thiosemicarbazones: The appropriate aldehyde (0.05 mol) 
thiosemicarbazone (0.025 mol), anhydrous sodium acetate (2.0g), ethanol (20 ml) and water (20ml) 
were stirred for 10 minutes. After this period, concentrated hydrochloric acid (0.5 ml) was added and 
the mixture was stirred overnight when a clear solution resulted. The precipitate was filtered and 
washed with ethanol and dried under vacuum. Further purification was achieved by recrystallization 
from methanol.  The characterization data of the individual ligands used in the present study have 
been disclosed in our earlier publication[49].(see supporting information)  
Copper complex formation: To a stirred solution of the thiosemicarbazones/thiosemicarbazones in 
methanol (1 mmol or 2 mmol) was added the appropriate copper salt (0.5 mmol or 1 mmol).The 
contents were allowed to reflux for 3 hours when a precipitate started appearing. The solution was 
cooled and the solid was filtered, washed with methanol and ether and subsequently dried in vacuum 
to furnish complexes with varying colors from green to orange red.  
Characterization data of selected copper complexes of ligands:  
L1: UV (MeOH) 250-350 (multiple peaks), 699nm. IR: 3469, 3220, 1699, 1646, 1576, 1569, 1472, 
1466, 1436, 1420, 1342, 1093, 851, 758, 688, 515, 461 cm
-1
.  
L3: UV (acetone): 253, 372 nm; IR: 3306, 3282, 3102, 1637, 1604, 1559, 1466, 1445, 1408, 1369, 
1317, 1230, 1167, 1154, 1106, 1016, 917, 883, 738, 546, 451, 438 cm
-1
. 
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L4: UV (acetone):326,370 and 690 nm; IR: 3411, 3194, 1691, 1569, 1498, 1396, 1240, 1150, 1086, 
1023, 826, 683, 561, 533, 451 cm
-1
 
L5: UV (not soluble), IR: 3306, 3282, 3101, 1636, 1604, 1558, 1465, 1445, 1418, 1316, 1301, 1230, 
1157, 1105, 917, 737, 672, 624, 547, 451, 439 cm
-1
.  
L6-: UV (MeOH/CH2Cl2):252, 350, 680nm; IR: 3301, 3199, 3034, 1639, 1605, 1580, 1557, 1519, 
1417, 1347, 1339, 1227, 1101, 1095, 776, 648, 519, 446 cm
-1
. 
EPR measurements details:  
X-band CW-EPR (Continuous Wave Electron Paramagnetic Resonance) power saturation 
measurements: CW-EPR spectra were measured with a Bruker Biospin Elexsys E500 CW-EPR 
spectrometer. The spectrometer had a 10in electromagnet in conjuction with a 12kW power supply 
(fields upto  1.4T), X-band (9-10GHz), a microwave bridge and a high Q cavity. This high Q cavity or 
quality factor indicates how efficiently the cavity stores microwave energy. As Q increases, the 
sensitivity of the spectrometer increases and this factor is defined by the ratio between the energy 
stored and energy dissipated per cycle.  It also possesed a 4131VT variable temperature unit 
connected by a liquid nitrogen gas flow tube.This was purposely used to ensure that the temperature 
of the sample is kept constant throughout the EPR measurements. Additionally the spectrometer 
consists of a Brucker Biospin teslameter (ER036TM) and an eIP 548B fequency counter.These 
counters were able to monitor the magnetic field calibrations  as well as the microwave frequency. A 
integrated PC system  with Mandriva Linux and the Bruker Biospin Xepr (v 2.66.45) was used to 
acquire data and to control the spectrometer. The Xepr  (X-band Electron Paramagnetic Resonance) 
was used to measure multidimensional EPR data sets during an experiment. 
Sample Preparation: The copper complexes of the semicarbazones and thiosemicarbazones were 
prepared by dissoling a known quantity (approximately 5mg) of the compounds in either methanol or 
dimethyl sulfoxide (3 ml). The homogenous solution was carefully transferred into the EPR tube by 
pasteur pipette so that the sample volume remained well below 1/5
th
 of the EPR tube length ( 
approximately 3cm). The sample was then frozen using liquid nitrogen in a dewar and the frozen 
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sample was quickly transferred into the precooled cavity of the EPR spectrometer. For 2-
pyridylthiosemicarbazonecopper the spectrum was recorded at microwave frequency = 9.3710 GHz, 
microwave power = 2mW, modulation amplitude =1G, temperature=140K, For 2-
nitrophenylthiosemicarbazonecopper the spectrum was recorded at microwave frequency = 9.4331 
GHz, microwave power = 20mW, modulation amplitude = 4G, temperature = 140K, EPR spectrum of 
4-nitrophenylsemicarbazonecopper(C3&C2) a) recorded at microwave frequency = 9.4348 GHz, 
microwave power = 20mW, modulation amplitude =4G, temperature = 140K, (see discussion on 
monomer and dimer formation in X-ray crystallography). 
Biological assay: 
PC-3 human prostate cancer cell line was purchased from the American Type Culture Collection 
(ATCC) and maintained in RPMI-1640 medium (Rosewell Park Memorial Institute) (Gibco, Thermo 
Fisher Scientific) supplemented with 10% (v/v) Foetal Bovine Serum (FBS; Bovogen, Australia), 50 
U.ml
-1
 penicillin, 50 μg.ml-1 streptomycin and 2 mM L-glutamine (Gibco, Thermo Fisher Scientific). 
Cells were grown in a 37 °C incubator with 5% CO2/air and passaged every 3-4 days. 
For cytotoxicity assays, 2 mg of each compound was dissolved in DMSO (Sigma Aldrich, hybri-max 
grade) to give a final concentration of 10 mg/mL for the ligands alone and 5 mg/mL for the ligands 
with copper. DMSO stock solutions were diluted into cell culture media with rapid mixing to give a 
final concentration of 100 µM test compound. The test compound solutions were prepared by dilution 
of dimethyl sulfoxide (DMSO) stocks of synthesized compounds into cell culture media which was 
then sterile filtered (0.22 µm; Millex, Millipore). and serially diluted to give media with 50 and 10 
µM of the compound. Final DMSO concentrations in media were 0.5 % (v/v) and 1.3 % (v/v) for 
ligands alone and ligands with copper respectively Final DMSO concentrations in media were <1.3% 
(v/v) and cellular proliferation was compared to control wells containing equivalent concentrations of 
DMSO with no test compound. Cells were seeded at 5,000 cells per well of 96-well plates and 
allowed to adhere in growth media overnight. Cells were then incubated with fresh growth media (100 
µL) containing synthesized chelators ± copper at 10, 50 or 100 µM (each in triplicate) for 
approximately 48 hours in a 37 °C incubator with 5% CO2/air. Cell viability was then assessed by 3-
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(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
assay (CellTiter 96 AQuesous One Solution Cell Proliferation Assay; Promega) following provided 
manufacturers methods. Briefly, wells were washed once with 200 µL growth media before addition 
of 100 µL of growth media containing 20% (v/v) MTS assay reagent. Plates were incubated for 1-2 
hours at 37 °C and absorbance at 490 nm of each well was measured. Absorbance readings of blank 
wells (no cells) were subtracted from all readings and then values were normalized (taking into 
account the values for DMSO alone) to cells grown in the absence of test compounds. Where 
necessary IC50 values for tested compounds were estimated using fitting of data using the Graphpad 
Prism Software version 6.05 (Graphpad Software). 
X-ray crystallography: X-ray crystallography: X-ray quality single crystals were obtained by slow 
diffusion of methanol to dichloromethane solution. Crystallographic data were acquired at 190 K on 
an Oxford Diffraction Gemini CCD diffractometer employing either Mo K radiation (0.71073 Å) or 
Cu K radiation (1.5418 Å) and operating in the -scan mode. Temperature control was achieved 
with an Oxford Cryosystems Desktop Cooler. Data reduction and empirical absorption corrections 
(multiscan) were performed with Oxford Diffraction CrysAlisPro software. The structure was solved 
by direct methods with SHELXS and refined by full-matrix least-squares analysis with SHELXL-97 
[50] within the WinGX graphical user interface [51]. All non-H atoms were refined with anisotropic 
thermal parameters. The molecular structure diagrams were produced with ORTEP3 [52] or 
PLATON.[53] The data in CIF format have been deposited at the Cambridge Crystallographic Data 
Centre. The structure of C3 was determined with a non-merohedrally twinned specimen (partially 
overlapping reflections) and refinement was performed on both twin components (HKLF 5 function). 
The following CCDC numbers contains the complete X-ray crystallographic data and the data can be 
obtained free of charge via http://www.ccdc.cam.ac.UK/conts/retreiving or from the Cambridge 
crystallography data centre. CCDC numbers: 1436285 – 1436289. 
 
Results and Discussion: Thiosemicarbazones and semicarbazones were synthesized following 
Schemes 1 and 2 shown below. In brief, appropriate aldehydes were treated with thiosemicarbazide or 
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semicarbazide in ethanol medium in the presence of sodium acetate to furnish the required 
thiosemicarbazones in good yield. The crude samples were further purified by re-crystallization using 
ethanol. The characterization data of individual semicarbazones and thiosemicarbazones have been 
disclosed in an earlier publication from this laboratory [49] The UV spectra of all the 
thiosemicarbazones in chloroform showed peaks at 309-330nm corresponding to the pi-pi transitions.( 
See supporting information) However the UV spectra of individual copper complexes had distinct 
peaks at various wavelengths. For example the 2-pyridyl semicarbazone had a visible peak at 660nm 
followed by a strong absorption peak at 355 nm in methanol/dchloromethane solvent. The 4- pyridyl 
thiosemicarbazone showed a similar trend and showed a strong absorption at 370nm. The p-nitro 
phenyl substituted semicarbazone showed a visible peak at 699nm followed by strong absorption 
peaks at 350 nm. The other thiosemicarbazones/semicarbazones showed similar trends in their 
UV/Visible spectral characteristics. 
The IR spectra of the complexes were analysed and the p-nitrophenyl semicarbazone copper complex 
showed strong absorption at 1698-1647 cm
-1
 indicating the presence of a C=O group in the molecule. 
Several other stretching vibration bands were observed between 1341-1559cm
-1
 indicative of the 
aromatic nucleus and the C=N character. Additional stretching bands between  447-499 cm
-1
 showed 
the presence of a copper coordinated complex in the structure of the molecule. The 2-pyridyl 
substituted semicarbazone copper complex showed stretching vibration for the NH group between 
3400-3200 cm
-1
 followed by a strong stretching band at 1605 cm
-1
 (C=O) and other stretching 
vibrations related to aromatic ring as well as C=N (1095-1518cm
-1
). The presence of the copper 
coordination is further manifested by vibrational bands between 460-518 cm
-1
. All the other 
thiosemicarbazones and semicarbazones exhibited a similar trend, confirming the presence of 
appropriate groups in the structure of the individual molecules. We also analysed infrared spectra of 
two additional new thiosemicarbazones with a furan and naphthyl ring in the structure in addition to 
the phenyl ring (Scheme 3). 
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The furan substituted thiosemicarbazone showed vibrational stretch between 3455-3294 cm
-1
 
indicative of the NH stretching followed by a strong absorption band at 1625-1590 cm
-1
 (C=O) and 
the phenyl stretching vibrations including the C=N stretch (1356-1543 cm
-1
) 
The NMR spectra of all the thiosemicarbazones and semicarbazones have been reported earlier [49] ( 
see supporting information) and the NMR (
1
H, 
13
C, 
15
N)  chemical shift values demonstrate the 
appropriate groups  attached to the structures of individual compounds. 
Syn and anti-isomerism:  Semicarbazones, thiosemicarbazones, phenyl hydrazones and oximes have 
the unique capability of forming syn and anti- isomers. Generally a mixture of isomers is synthesised 
depending on the experimental conditions used to prepare the compounds. An example of syn- and 
anti-isomers of a thiosemicarbazone is shown in Scheme 4. 
It is evident from Scheme 4 that for the anti-isomer (E), the chemical environment of the NH proton 
should be different to syn (Z) isomer.  This is due to the proton of the NH group being in closer 
proximity to the aromatic protons for the syn- isomer than the anti-isomer [54]. The NMR spectra for 
all the compounds reported in our study showed only one set of peaks, demonstrating the preferential 
formation of one isomer over the other or a fast exchange between the two isomers 
To examine whether it is viable to synthesise any of the compounds in the present study as the syn 
isomer, the anti-isomers were refluxed in methanol using silica gel as a catalyst [54] Thin layer 
chromatography revealed that only 2-pyridyl thiosemicarbazone formed the syn isomer. A fresh 
sample of the syn isomer of 2-pyridyl thiosemicarbazone was prepared and dissolved in DMSO-d6 
and the proton NMR acquired. ( see supporting information).  
The NMR spectrum showed a peak at 14 ppm, similar to that reported by previous workers. [54-55] It 
was evident from the NMR that the chemical shift for the NH group protons as well as the aromatic 
protons associated with the structure of the molecule differs between isomers. The downfield shift of 
the NH protons for the syn thiosemicarbazone demonstrates that there is hydrogen bonding between 
the NH groups and the aromatic nitrogen. The 
1
H spectrum was acquired at various time intervals 
over an 18 hour period. The peak at 14 ppm (H3, syn) decreased in intensity with a corresponding 
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increase in the peak at 11.6 ppm (H3, anti). A plot of the formation of the anti-isomer in Figure F1( 
see supporting information) follows a first order rate equation with a rate constant of 2.4x10
-3
/min. 
Figure F2 compares the starting 
1
H NMR spectrum, the corresponding spectra approximately half way 
through the conversion and the final spectrum of the anti- compound and Figure F3 shows a 
13
C 
HSQC at approximately 50% conversion showing the two isomers. In the case of copper complex of 
ligand 4, two types of crystals were obtained, and each of these crystals were dissolved in d6-DMSO 
and the 
1
H NMR spectra taken ( see supporting document). As can be seen from the proton NMR 
spectra, the two crystals showed slight difference in chemical shift values of the aromatic protons 
associated with the structure of the ligand. The largest being from 9.32 to 8.68 ppm.  Subsequently, a 
DOSY experiment was performed for the individual crystals and as can be seen from the over lay of 
individual DOSY spectra ( see supporting document), both compounds showed a very similar 
diffusion coefficient. 
Additionally, molecular modelling studies were undertaken. The compounds were initially 
investigated by a Monte Carlo conformational search (MacroModel, Schrodinger) and the 
conformations with 3 kcal/mol were then further optimized using DFT calculation (Gaussian 09) with 
the inclusion of the polarizable continuum model (IEF-PCM)  and solvent model for DMSO and the 
2-pyrdiyl thiosemicarbazone and the syn and anti-isomers had two different conformations with the 
lowest energy syn isomer (planar conformation) being 0.2 kcal/mol lower energy compared to the 
lowest anti isomer (planar conformation). The alternate conformation was much higher in energy. In 
the present study, the observed chemical shifts for this proton showed the preferential formation of 
anti-isomer due to its lower energy state. Both isomers were examined by DFT which showed that the 
anti- isomer was about 5.3 kcal/mol lower energy than the syn isomer explaining why only the anti-
isomer was formed. The syn isomer was not planar due to steric interactions from the protons H7 and 
H11. (see supporting information) 
Keto- enol tautomerism : 
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An interesting feature regarding the structure of semicarbazones is that in solid state most of the 
semicarbazones exhibit a keto form whereas in solution state they may exhibit keto-enol tautomerism 
as shown below in chart 1: 
The keto form acts as a bidendate  ligand while the enol form can lose the proton and act as an anionic 
bidendate ligand in complexes. Substituents on the aromatic ring can further enhance the electron 
density through delocalization enabling the semicarbazone to form chelate complexes with metal ions. 
In the present study, the X-ray crystal solid state structure confirms that the semicarbazones exist in 
keto form as expected. The 
13
C NMR spectrum of these compounds in solution state tend to show the 
same evidence for an keto form as evidenced from the chemical shift values of the carbon atom 
associated with the carbonyl oxygen of the semicarbazone.  
X-ray crystal studies 
The single crystal X-ray studies were conducted and the details are shown in the supporting 
documents for further reference. The crystal structure of the semicarbazone L1 was determined 
(Figure 1,  also refer supporting information for details). The ligand crystallises as the E-isomer 
(Figure 1) with the N1-N2 and C1-C7 bonds in a trans disposition. The C8-O and C8-N2 (1.246(2) 
and 1.368(2) Å respectively) bonds are consistent with the keto (amide) tautomer. 
The semicarbazone moiety is involved extensively in intermolecular H-bonding as shown in Figure 2. 
All three N-H protons donate H-bonds to either the semicarbazone O-atom (O1) or (intramolecularly) 
to the imine (N1). In fact all of the H-bonding interactions occur in this region of the molecule and the 
nitro group at the opposite end of the molecule in not involved at all in any way as an H-bond 
acceptor. The H-bonding pattern comprises a ribbon of L1 molecules each related by the 2-fold screw 
axis symmetry element in the direction of the b axis. Each ribbon is linked to a centrosymmetric 
ribbon via an H-bond donated by N2-H to O1 on a molecule above or below the plane of view in 
Figure 2 (not shown here for clarity). 
The X-ray single crystal structure of the pyridyl-substituted semicarbazone L4.H2O is shown in 
Figure 3. The ligand occupies a general site while a water molecule (not shown in Figure 3) is found 
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on a 2-fold axis (at half occupancy). Again the E-isomer of the Schiff base is present. The C8-O1 and 
C8-N2 bond lengths are consistent with the keto tautomer (1.244(2) and 1.366(2) Å respectively) and 
the N2-H proton was clearly seen in the difference electron density map. 
H-bonding in this structure is distinctly different from that seen in L1. The syn oriented N2 (H)-C8-
O1 moiety forms a centrosymmetric H-bonded dimer. Each dimer is linked to four others via H-bonds 
involving the terminal –NH2 group (N3) and the carbonyl O-atom (O1) (Figure 4). The water bridges 
adjacent molecules through H-bonds made with pyridyl rings on either side. 
Reaction of L1 with Cu(OAc)2 led to the compound with the formula [Cu2(OAc)2(L1)2].(L1)2 Figure 5 
shows the structure of the complex [Cu2(OAc)2(L1)2] which is a centrosymmetric dinuclear tetra-2-
(κO:κO′) acetato-bridged dicopper complex of ligand L1. Two of the L1 molecules are ligated by 
their semicarbazide O-atom to the axial coordination site of each Cu ion while the other 2 are not 
coordinated. All four L1 molecules are found in the keto tautomeric form and their internal bond 
lengths are not significantly different. In other words coordination of the O-donor has no bearing on 
the intramolecular bond lengths. Each Cu ion is coordinated by five O-donor ligands; four acetato 
ligands occupying the equatorial plane in addition to an axially bound semicarbazone. A strong 
Cu…Cu interaction is found (2.6378(7) Å). An intramolecular H-bond donated by the terminal –NH2 
group to an adjacent acetate ligand is apparent in Figure 5 and buttresses the Cu-O1a coordinate bond. 
The non-coordinated L1 molecule (not shown for clarity) forms several H-bonds within the structure, 
the most significant as an H-bond donor to one of the coordinated acetato O-donors (N2b-H…O4 2.30 
Å). 
Crystal structures of similar so-called „magic lantern‟ tetraacetato-bridged dicopper(II) complexes 
abound in the literature [55-61] and more than 280 examples are to be found in the Cambridge 
Structural Database. Monodentate coordination through O1a would not normally be expected over 
bidentate (O1a/N2a) coordination accompanied by deprotonation at N3a. Perhaps the structural 
rigidity of the Cu2(OAc)4 core precludes coordination by anything except a monodentate ligand. 
Normally the reaction of such a ligand with Cu(II) in a ration 2:1 ratio ligand:copper would lead to a 
bis-chelate CuN2O2 complex with this reaction being assisted by deprotonation at N3a by a base such 
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as Et3N, NaOH or NaOMe although base is not always required [62-65]. In this reaction the acetate 
anions could potentially accept a proton from N3a but instead they are consumed stoichiometrically in 
forming the Cu2(OAc)4 cluster. Formation of the Cu-acetate bonded complex using the semicarbazone 
ligands is consistent with reports in the literature [55-61] and reflect the inherent stability of the 
(Cu2(OAc)4) core.  
Certain copper complexes of thiosemicarbazone and semicarbazone compounds are described to 
dissociate in solution [66].  For example for tridentate thiosemicarbazone, in frozen DMSO, the dimer 
remains intact, but in aqueous solution it converts to [Cu(Fotsc)(H2O)]
+
  (Fotsc: formyl pyridine 
thiosemicarbazone).  
The complexation reaction between Cu (OAc)2  and L4 led to two distinct types of complexes with the 
same stoichiometry of metals and ligands. The first is shown in Figure 6 comprises a centrosymmetric 
monomeric compound bearing a pair of trans pyridyl-coordinated L4 ligands in addition to a pair of 
asymmetrically bound acetato ligands (Figure 6).  
The Cu-O distances (Cu-O2 1.937(1) and Cu-O3 2.731(1) Å) are vastly different, the longer contact 
being too distant to be considered a proper coordinate bond. Thus the coordination geometry is 
basically distorted square planar. There is an extensive network of H-bonds that involve the non-
coordinated water molecule and this is apparent in Figure 7.  
It is noteworthy that none of the other atoms of the semicarbazone moiety was involved in the 
coordination of copper, including the O-donor of the semicarbazone group. This is contrary to the 
structure observed for the 4-nitrophenyl semicarbazone ligand wherein the C=O group of the 
semicarbazone was indeed involved in the coordination sphere of the copper. The superior pyridine 
donor is bound instead and again the ligand is not deprotonated thus disfavouring formation of an N,O 
chelate. 
We also isolated a diuclear Cu complex from this reaction (Figure 8). Apart from the number of water 
molecules in the asymmetric unit, the Cu:ligand stoichiometry is the same as in the structure of 
monomeric [Cu(OAc)2(L4)2].2H2O. The dimer occupies a crystallographic two-fold axis and one pair 
of symmetry related acetato ligands bridge the two metals in a 2:O mode (through O3) while 
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another pair of acetates bind as monodentate terminal ligands (through O5). Again the pyridyl donor 
binds in preference to the semicarbazone moiety. The Cu…Cu distance is 3.476 Å in this particular 
bridging mode, which is also well known in the literature (more than 70 examples in the Cambridge 
Structural Database). 
It is interesting that two complexes of the same metal:ligand stoichiometry have been isolated here. 
This can be rationalised by comparing the two Cu (OAc)2(L4)2 fragments as seen in Figure H viewed 
along the N-Cu-N axis. The monomeric complex finds the two trans acetato ligands oriented in an 
anti conformation such that the two weakly coordinated (or non-coordinated) O-atoms (O3) block the 
axial sites on both sides of the CuN2O2 plane thus preventing dimer formation. On the other hand in 
the structure of the dimer the acetato ligands are in a syn conformation (O4 and O6 are on the same 
side of the CuN2O2 plane). Now that O4 is out of the way, O3 is then able to act as a bridging ligand 
to another Cu ion and the dimer in Figure 9 (right) assembles.  
The coordination modes of the copper complexes based on the X-ray crystallography as illustrated 
below (chart 2) for clarity and simplicity. As can be seen, depending on the ligands nature the 
coordination of the copper is altered although in most of the complexes acetate is involved and the 
copper is coordinated through the oxygen. In the case of ligand L1, the C=O of the semicarbazone 
moiety is also involved in the coordination as discussed previously. In the case of L1 the copper 
complex shows as a pentacoordinated species and L4 complex shows both a tetra and penta 
coordinated geometry. Thus the nature of the ligand seems to play a significant role towards the 
coordination modes of copper complexes. (see chart 2 below) 
EPR spectral studies 
EPR characteristics of copper complexes of several semicarbazones have not been described 
extensively in the literature although isopropyl group substituted thiosemicarbazones and 
semicarbazones have been described in the literature [67]. We have also examined the EPR spectra of 
the 4-nitrophenyl and 2-nitrophenyl copper acetate complexes. Two of the thiosemicarbazone EPR 
characteristics are also presented for comparative purposes.  
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Figure 10 shows the EPR spectrum of the 2-pyridyl semicarbazone (L6) copper complex in dimethyl 
sulfoxide at 140K. The upper panel shows the experimentally observed spectrum and the lower panel 
shows the simulated spectrum. It is evident from the spectra that there are four distinct lines observed 
in the spectra which is typical of a copper species. Figure 11 shows the EPR spectrum of the 
corresponding thiosemicarbazone (L5) copper complex under similar conditions  The peaks are not 
well resolved in this case, however on subtraction of Savitzky-Golay (third order, 55 points) filtered 
data, the nitrogen super hyperfine spectra are revealed as predicted by the simulation.  Figure 12 
shows the 2-nitrophenylthiosemicarbazone (L7) copper complex monomer and Figure 13 shows the 
4-nitrophenyl semicarabzone (L1) copper complexes respectively. The monomer of the 2-nitrophenyl 
semicarbazone (L8) copper complex is well resolved and the computer-simulated spectra coincide 
well. The EPR spectra of 4-nitrophenyl semicarbazone (L1) copper complex showed the presence of a 
momomer and a dimer. Panel a shows the experimental spectrum of both the species while panel b 
shows the computer simulated spectra for the above mixture. Panel c and d shows the simulated 
spectra for both the dimer and the monomer copper species. It is evident from the Figures that the 
experimental spectra are very close to simulated spectra. Further confirmation of the monomer and 
dimer species is provided by single crystal X-ray crystallographic studies for  (see discussion in the 
X-ray section).  
Table 1 shows the gx, gy and gz values observed for the respective copper complexes. For the 2-
pyridyl semicarbazone (L6) the values ranged from 2.065-2.260. On the other hand the corresponding 
thiosemicarbazone (L5) showed values ranging from 2.050-2.185. The most striking features of the 
EPR spectral data were observed in the case of the monomer and dimer Cu-complexes of the 
nitrophenyl semicarbazone derivatives. The dimer showed a considerable increase in the gz value 
(2.300). In general the trend was similar for each of the complexes studied in the present study. 
Previous studies on 2-pyridine copper complexes showed values in the range of 2.114-2.029 at room 
temperature. [68-73] In another study by Raphael et al. [74] the N-4-substituted thiosemicarbazones 
showed a dimer consisting of two square pyramidal Cu(II) centers based on the EPR data and X-ray 
crystallography. Several other studies on this 2-pyridyl-methylsubstituted thiosemicarbazone yielded 
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a value ranging from 2.201-2.081[75-78].  The lower value observed in this complex can be attributed 
to the introduction of a methyl group in the structure of the 2-pyridine thiosemicarbazone. Based on 
the literature precedence on the characteristics of the EPR spectral interpretation we were able to 
ascertain that the following trend is associated with the copper complexes as described in the 
following paragraphs.   
The complexes dissolved in DMSO showed typical EPR spectra of Cu
2+
 with four peaks at low field 
and one or two at high field. The EPR parameters determined from the spectra g// > g┴ indicates that 
unpaired electron is predominantly in the dx2-y2 orbital and the copper ion has octahedral 
coordination. One of the compounds (2-pyridyl thiosemicarbazone) showed resolved nitrogen super 
hyperfine lines. The super hyperfine splittings were best fitted with three nitrogens coordinating to the 
copper. One of the compunds (2-nitrophenylsemicarbazone) showed peaks at zero field and at 
approximately 470 mT in addition to the peaks at g~2. These peaks could be simulated with a strongly 
exchange coupled Cu-Cu pair with anistropic dipole-dipole exchange interaction and a distance of 
approximately 2.74Å. These peaks could be simulated with a strongly exchange coupled Cu-Cu .Thus 
the EPR spectral data were consistent with the results obtained from X-ray single crystal studies for 
the copper complexes studied.  
Biological studies: 
 Knowledge of the biological activity of novel chelators is key in determining their utility in future 
applications. To this end, the human prostate cancer PC-3 cell line was incubated with varied 
concentrations or doses (10, 50 and 100 µM) of the synthesized compounds to assess their biological 
activity. Caution should be exercised in terms of the solubility constraints of these 
thiosemicarbazones. The semicarbazones and the thiosemicarbazones were soluble in DMSO solvent 
( upto 10mg/ml) and therefore we chose this solvent to dissolve respective semicarbazones and 
thiosemicarbazones as well as the copper complexes used in the present study. As stated in the 
methods section, test compounds were solubilized in DMSO and then diluted into cell culture media 
to achieve desired final concentrations. Media were then sterile filtered before being added to wells 
containing PC3 cells. Final DMSO concentrations in media were <1.5% (v/v) and cellular 
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proliferation was compared to control wells containing equivalent concentrations of DMSO with no 
test compound. All test compound solutions that included copper were prepared using similar 
methods to achieve equivalent concentrations of test compound and copper. Thus if copper alone were 
causing cytotoxicity it would be expected to do so for all samples tested, which was not observed  
demonstrating that copper is not causing the toxicity to the cells. Table 2 shows determined IC50 
values of all tested compounds. 
The anticancer activity of several thiosemicarbazones have been previously examined and showed 
extremely high anti-proliferative activity, typically falling between 4.7-30 µM for the colon, 
lymphoma, cervical carcinoma, and neuroepithelioma cancer cell lines [26]. However, our interest 
was to find out the anti-proliferative effect in prostate cancer cell lines.  
In the absence of copper, only 2-pyridyl thiosemicarbazone decreased cellular proliferation in our 
studies (Figure 14, Table 2) to a measurable extent; cells incubated with a range of concentrations of 
this ligand showed less than 50% cell proliferation compared to the untreated control cells. The other 
compounds in the series were found to be less potent or inactive under our experimental conditions 
for the cell lines investigated in this study.  In comparison, copper-complexed derivatives showed a 
much larger influence on cellular proliferation (Figure15, Table 2). The copper-coordinated 
complexes showed varied efficacy in decreasing cellular proliferation following the trend 2-pyridyl 
thiosemicarbazone (L5) > 4-nitrophenyl thiosemicarbazone(L2) > 4-pyridyl thiosemicarbazone(L3) > 
4-nitrophenyl semicarbazone(L1) > 4-pyridylsemicarbazone (L4)>2-pyridyl semicarbazone (L6). At 
all concentrations tested, cells incubated with L5+Cu showed no measureable cellular activity. This 
was also seen for cells incubated with 100 µM L2+Cu and L3+Cu. Lower concentrations of L2+Cu 
and L3+Cu showed higher levels of cellular proliferation; cells incubated with 10 and 50 µM L2+Cu 
showed proliferation at approximately 29 and 31% the rate of control cells respectively, while those 
incubated with 10 and 50 µM L3+Cu showed proliferation at approximately 29 and 31% the rate of 
control cells respectively, while those incubated with 10 and 50 µM L3+Cu showed proliferation at 
approximately 68 and 37% of controls respectively  At all concentrations tested, cells incubated with 
L1+Cu, L4+Cu and L6+Cu showed proliferation rates similar to untreated controls. The above results 
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demonstrate that copper complexes of ligands L1, L4 and L6 are likely not useful as anticancer agents 
for the prostate. In contrast, copper complexes of L2 and L5 showed significant activity and from the 
structural consideration both these ligands contained a sulphur atom rather than oxygen 
(thiosemicarbazone vs semicarbazones). Therefore, we conclude that semicarbazones are generally 
non-active compared to thiosemicarbazones. This is consistent with literature reports [26] in which 
the introduction of a sulphur atom markedly improves the activity of these copper complexes of 
semicarbazones. Thus the observed results for copper chelates of a few thiosemicarbazones are 
interesting because of the marked biological activity displayed. It may be useful to explore these 
compounds further for therapeutic application for prostate cancer.  
An interesting question arises as to why the copper complexes of ligand 2 and 3 differs in their 
biological activity?  To address this issue we examine their X-ray crystal structures to examine the 
whether the coordination mode of the complex affects the biological profile. Examination of the 
crystal structure of the copper complexes revealed the following trend. The X-ray crystal structure of 
two of the complexes, the p-nitro substituted semicarbazone and the 4-pyridyl substituted 
semicarbazone indicated that the coordination of the copper was considerably altered For example, 
the nitro compound forms a copper –oxygen bond in the complex while the corresponding pyridyl 
compound does not form a bond between oxygen and it prefers the nitrogen center of the aromatic 
ring. In the first case, the copper is five coordinated (including the acetate ions) while in the second 
case it is a four coordinated species. 
We do not have the crystal structure details for the L2 and L3 copper complexes, which possess 
similar structural features except that the oxygen is replaced with the sulphur (thiosemicarbazones) 
but on  our intuition is that a similar behaviour for copper coordination is seen in these compounds. 
As can be seen from the biological data, the L3 copper complex shows a slight increase in activity 
compared to the L2 copper complex. Therefore a four coordinated pyridine copper complex seems to 
be slightly better than a nitro substituted compound.  This is in accordance with the results obtained 
for a variety of copper complexes coordinated through the pyridine nitrogen atom [79]. In addition, 
studies have shown that coordination modes of copper complexes of Schiff bases derived from 
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coumarin based ligands does affect biological activity.[80] However, we stress that in solution state, 
the involvement of solvent molecules may disrupt the coordination of the copper ion which may be 
entirely different to that observed in the solid state.  
PC-3 cells are an extensively studied disease model and in this case are used as an archetypal example 
of human cancer cell lines. Future studies will be required to determine variability in biological 
activities across alternate cell lines. Suffice to say that among the compounds examined in the present 
study, only the thiosemicarbazones possessed anticancer activity and none of the semicarbazones or 
their copper complexes exhibited significant biological activity.  The activity shown by only 
thiosemicarbazones instead of any semicarbazones may be rationalized by potential structural 
differences. The canonical form of thiosemicarbazones compared to the semicarbazones is shown in 
Scheme 6. The tendency of sulphur compounds to form such an equilibrium is known and also the X-
ray crystal structure of free ligands generally shows a C=O for semicarbazones while it tends to show 
the C-S bond somewhere between what is expected for a single and double bond. The superior 
activity shown by thiosemicarbazones is perhaps due to the reaction taking place in the cellular 
machinery shown in Scheme 7. 
The above proposal is consistent to previous literature reports [81-84] relating to anti-HIV activity 
and anti-cancer activity of thiourea derivatives compared to urea derivatives. There is similarity 
between the structural features of thiourea compounds and thiosemicarbazones. In the above pathway 
there are three different mechanism which can affect cellular biochemical pathways. In the first 
pathway, a nucleophilic substitution by the OH is invoked. The hydroxyl anion from water or basic 
components in the cells attacks the double bond and releases the positive charge on the nitrogen atom 
to form the intermediate hydroxy thiol which subsequently eliminates the SH group and a proton to 
form the semicarbazone. In the second pathway, a free radical process is invoked in which hydroxyl 
free radical with a singlet oxygen radical species directly converts the thiosemicarbazone to the 
semicarbazone derivative by eliminating hydrogen sulfide and regenerating the hydroxyl radical once 
again. In the last pathway, the singlet oxygen generated by superoxide dismutases which acts as a 
radical quencher can combine with the sulphur atom of the thiosemicarbazone to give a sulfoxide or 
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sulfinic acid intermediate together with the formation of sulphur, sulphur dioxide and ammonium 
sulfate.  It has been reported that, experimentally, chemical oxidation of thiourea derivatives with a N-
bromosuccinamide and dioxane/water mixture forms the urea derivative [81]. In a similar manner 
sulphur containing thiosemicarbazones may affect the biochemical processes to exert its anti-cancer 
effects. Recently, a complete review of the anticancer activities of thiosemicarbazones has been 
reported [30]and  the key biological role is often related with their capability to inhibit the enzyme 
ribonucleotide reductase, similar to what is observed with potent anticancer drugs such as triapine and 
methisazone.  
Additional studies have also revealed that thiosemicarbazones can inhibit topoisomerase II enzyme. 
Serda et al [26] have conducted extensive studies with thiosemicarbazones and their studies of 
structure-activity relationship showed the chelators that utilized “soft” donor atoms, such as nitrogen 
and sulfur, resulted in potent anti-cancer activity. Indeed, the N,N,S donor atom set was crucial for the 
formation of redox active iron complexes that were able to mediate the oxidation of ascorbate. This 
further highlights the important role of generation of reactive oxygen species in mediating potent anti-
cancer activity. Although this mechanism may be feasible in the ligands containing a sulphur atom in 
their structure, it is not known whether it occurs with copper complexes of these ligands since the 
sulphur atom of the thiosemicarbazones or oxygen atom of the semicarbazones coordinates with the 
copper.  
Conclusions: Detailed studies on the structural characteristics of several semicarbazones and 
thiosemicarbazones have been conducted. The EPR spectral data showed that the copper complexes 
exhibit a similar type of coordination geometry to that observed for several other copper complexes 
described in the literature. The 4-nitrophenyl semicarbazone copper acetate complex formed both a 
monomer and dimer and the solution EPR study confirmed this. Further confirmation came from the 
X-ray single crystal studies. Interestingly we were able to observe that copper is only coordinated to 
the acetate anion and there was no evidence of formation of a copper complex between two 
thiosemicarbazone or semicarbazone ligands which was originally expected. This was despite the use 
of 2 moles of the ligand for every mole of copper ion. Biological studies on several of the copper 
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complexes of these ligands provided evidence that only thiosemicarbazone ligands and their copper 
complexes had any significant anticancer activity against prostate cancer cells. A mechanism for the 
biological activity shown by the thiosemicarbazone compounds is proposed which involves three 
different pathways involving a nucleophilic attack, a free radical pathway and finally a singlet oxygen 
induced by superoxide dismutase in the cells 
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Figure captions: 
Figure 1: ORTEP view of L1(30% probability ellipsoids) showing the atomic nomenculture 
Figure 2: PLATON view of H-bonding in the structure of compound L1 
Figure 3: ORTEP plot (30% probability ellipsoids) of L4 (water molecule not shown) 
Figure 4: PLATON view of the H-bonding in compound L4.H2O 
Figure 5: ORTEP plot(30% probability ellipsoids) of [Cu2(OAc)4(L1)2]. Selected bond 
lengths (Å): Selected bond lengths (Å): Cu(1)-O(2) 1.956(2); Cu(1)-O(3) 1.957(2); Cu(1)-
O(1) 1.971(2); Cu(1)-O(4) 1.973(2); Cu(1)-O(1A) 2.243(2); Cu(1)-Cu(1)′ 2.6378(7). 
 
Figure 6. ORTEP plot (30% probability ellipsoids) of [Cu(OAc)2(L4)2] (water molecule 
omitted). Selected bond lengths (Å): Cu(1)-N(1) 2.038(1); Cu(1)-O(2) 1.937(1); Cu(1)…O(3) 
2.731(1). 
 
Figure 7: PLATON view of the Figure G. PLATON view of the [Cu(OAc)2(L4)2].2H2O unit 
cell showing H-bonding interactions unit cell showing H-bonding interactions. 
 
Figure 8: ORTEP view of dimeric [Cu2(OAc)4(L4)4].9H2O (30% probability ellipsoids). 
Water moelcules omitted. Selected bond lengths (Å): Cu(1)-N(1) 2.007(3); Cu(1)-N(5) 
2.022(3); Cu(1)-O(3) 1.972(3); Cu(1)-O(5) 1.924(3) Cu(1)-O(3′) 2.560(3). 
 
Figure 9: Figure H. PLATON views of the monomeric (left) and dimeric (right) Cu 
complexes of L4 viewed along the N-Cu-N axis (H-atoms and water molecules omitted for 
clarity). The different orientation of the acetato ligands is apparent. 
Figure 10. EPR spectrum of 2-pyridylsemicarbazonecopper. a) experimental b) computer 
simulation. Peaks corresponding to a second species not included in the simulation are 
marked with an asterisk. 
Figure 11 
EPR spectrum of 2-pyridylthioscarbazonecopper. a) experimental b) computer simulation, c) 
experimental spectrum after subtracting Savitzky-Golay (third order, 55 points) filtered data 
to reveal nitrogen superhyperfine, d) computer simulation of the filtered data. 
Figure 12 
EPR spectrum of 2-nitrophenylthiosemicarbazonecopper.  a) experimental b) computer 
simulation. Peaks corresponding to a second species not included in the simulation are 
marked with an asterisk. 
Figure 13 
EPR spectrum of 4-nitrophenylsemicarbazonecopper (C3&C2) a a) experimental b) 
computer simulation. Peaks from the dimeric species are marked with an asterisk.  
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Figure 14 Ligands activity towards cancer cells in dimethylsulfoxide medium 
Figure 15.  Copper complexes of ligands activity towards cancer cells in dimethyl sulfoxide 
medium 
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Figure 15 
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Tables: 
Table 1: g values obtained for some of the copper complexes of semi and thiosemicarbazones 
 
Table 2:   IC50 values determined for each of the test compound 
 
Table 1: 
 2-
pyridylsemic
abazone 
(L6) 
2-
pyridylthio
semicarba
zone 
(L5) 
p-
nitrophenyls
emicarbazon
e dimer(C3) 
p-
nitrophenylsemicar
bazone 
monomer (C2) 
2-
nitrophenylthiosemi
carbazone 
(L8) 
gx 2.055 2.050 2.040 2.060 2.025 
gy 2.065 2.050 2.040 2.060 2.028 
gz 2.260 2.185 2.300 2.290 2.140 
Ax (10-4cm-1 ) 10.0 40.0 10.0 10.0 25.0 
Ay (10-4cm-1 ) 10.0 10.0 10.0 10.0 25.0 
Az (10-4cm-1 ) 162.0 188.0 164.0 170.0 152.0 
AxN (10
-4cm-1 )  13.0   10 
AyN (10
-4cm-1 )  13.0   10 
AzN (10
-4cm-1 )  14.0   11 
D (cm
-1 )   0.131   
r  (Å
 )   2.74   
      
 
 
Table 2 
Ligand Chelator Alone (µM) Chelator + Cu (µM) 
L1 >100 >100 
L2 >100 <10 
L3 >100 33 
L4 >100 >100 
L5 <10 <10 
L6 >100 >100 
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Chart captions 
Chart 1: Chart depicting the  Keto-entol tautomerism of semicarbazones 
Chart 2: Coordination modes of few of the copper complexes observed for semicarbazones 
Chart 1: 
 
 
 
Chart 2 
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Highlights 
*Synthesis of semicarbazones and thiosemicarbazones 
*Synthesis of Copper complexes of semicarbazones 
*Single crystal X-ray studies of copper complexes 
*EPR studies of copper complexes  
*Biological activity of copper complexes of thiosemicarbazones and semicarbazones 
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Graphical Abstract 
Synthesis, characterisation and biological activities of semicarbazones and their copper 
complexes. 
Taracad.K.Venkatachalam*, Paul. V. Bernhardt
#
, Chris.J.Noble, N.Fletcher, Gregory.K.Pierens,  
Kris.J.Thurecht, David.C.Reutens (Centre for Advanced Imaging, 
#
School of Chemistry University of 
Queensland,  St.Lucia, Brisbane 4072, Australia.  
 
Abstract: Substituted semicarbazones have been prepared and their single crystal structure was 
determined. Electron paramagnetic resonance of few of the copper complexes showed consistent trend 
to those observed by single crystal X-ray crystallography. Interestingly, only the copper complexes of 
thiosemicarbazone showed anticancer activity. 
 
 
